The FDA has granted orphan drug designation to ligufalimab, a CD47 monoclonal antibody, for treatment of acute myeloid leukemia. Treatment for blood cancers has significantly improved over the past ...

New materials and a novel process could aid efforts to develop smaller, faster, and affordable microchips to power a range of modern electronics ...